2023 Q4 Form 10-Q Financial Statement
#000107997323001561 Filed on November 13, 2023
Income Statement
Concept | 2023 Q4 | 2023 Q3 | 2022 Q3 |
---|---|---|---|
Revenue | |||
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $629.0K | $660.0K | $866.5K |
YoY Change | 3.54% | -23.83% | 76.43% |
% of Gross Profit | |||
Research & Development | $7.431K | $8.299K | $28.44K |
YoY Change | -50.94% | -70.82% | -53.98% |
% of Gross Profit | |||
Depreciation & Amortization | $460.00 | $461.00 | $330.00 |
YoY Change | 16.75% | 39.7% | 32.0% |
% of Gross Profit | |||
Operating Expenses | $643.9K | $675.0K | $895.3K |
YoY Change | -0.34% | -24.6% | 61.84% |
Operating Profit | -$643.9K | -$675.0K | -$895.3K |
YoY Change | -0.34% | -24.6% | 61.84% |
Interest Expense | -$74.68K | -$70.00K | $26.10K |
YoY Change | -187.57% | -368.25% | -123.57% |
% of Operating Profit | |||
Other Income/Expense, Net | -$74.68K | -$70.53K | -$24.16K |
YoY Change | -11.0% | 191.94% | -78.17% |
Pretax Income | -$718.6K | -$750.0K | -$919.4K |
YoY Change | -1.56% | -18.43% | 38.49% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$718.6K | -$745.5K | -$919.4K |
YoY Change | -1.56% | -18.91% | 38.6% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | -$0.01 | -$0.02 | -$0.02 |
Diluted Earnings Per Share | -$0.01 | -$0.02 | -$21.16K |
COMMON SHARES | |||
Basic Shares Outstanding | 48.80M shares | 48.70M shares | 43.42M shares |
Diluted Shares Outstanding | 48.75M shares | 48.62M shares | 43.45M shares |
Balance Sheet
Concept | 2023 Q4 | 2023 Q3 | 2022 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $384.7K | $140.0K | $1.898M |
YoY Change | -65.07% | -92.62% | -52.1% |
Cash & Equivalents | $384.7K | $140.4K | $1.898M |
Short-Term Investments | |||
Other Short-Term Assets | $9.390K | $30.00K | $135.3K |
YoY Change | -88.04% | -77.82% | 48.14% |
Inventory | |||
Prepaid Expenses | $3.394K | $16.28K | $134.3K |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $394.1K | $162.6K | $2.033M |
YoY Change | -66.6% | -92.0% | -49.84% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $9.111M | $7.621M | $3.249M |
YoY Change | 137.5% | 134.58% | 5091.13% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $9.177M | $7.701M | $3.381M |
YoY Change | 131.96% | 127.74% | 5303.47% |
TOTAL ASSETS | |||
Total Short-Term Assets | $394.1K | $162.6K | $2.033M |
Total Long-Term Assets | $9.177M | $7.701M | $3.381M |
Total Assets | $9.571M | $7.863M | $5.415M |
YoY Change | 86.35% | 45.22% | 31.55% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.648M | $1.270M | $549.4K |
YoY Change | 406.04% | 131.15% | 156.46% |
Accrued Expenses | $76.50K | $80.00K | |
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $250.0K | $0.00 | |
YoY Change | -100.0% | ||
Total Short-Term Liabilities | $4.200M | $2.418M | $1.204M |
YoY Change | 239.39% | 100.88% | -89.24% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $1.740M | $1.680M | $5.212M |
YoY Change | -67.17% | -67.77% | 6.53% |
Other Long-Term Liabilities | $0.00 | $10.00K | $132.1K |
YoY Change | -100.0% | -92.43% | |
Total Long-Term Liabilities | $1.740M | $1.690M | $5.344M |
YoY Change | -67.99% | -68.38% | 9.22% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $4.200M | $2.418M | $1.204M |
Total Long-Term Liabilities | $1.740M | $1.690M | $5.344M |
Total Liabilities | $5.940M | $4.115M | $6.548M |
YoY Change | -10.99% | -37.16% | -59.37% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$128.7M | -$128.0M | -$125.0M |
YoY Change | 2.39% | 2.41% | |
Common Stock | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $3.593M | $3.711M | -$1.171M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $9.571M | $7.863M | $5.415M |
YoY Change | 86.35% | 45.22% | 31.55% |
Cashflow Statement
Concept | 2023 Q4 | 2023 Q3 | 2022 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$718.6K | -$745.5K | -$919.4K |
YoY Change | -1.56% | -18.91% | 38.6% |
Depreciation, Depletion And Amortization | $460.00 | $461.00 | $330.00 |
YoY Change | 16.75% | 39.7% | 32.0% |
Cash From Operating Activities | -$50.65K | -$395.4K | -$1.316M |
YoY Change | -91.64% | -69.95% | 275.97% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $323.8K | $164.4K | $322.7K |
YoY Change | -22.31% | -49.05% | -4408.33% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | -$323.8K | -$164.4K | -$322.7K |
YoY Change | -22.31% | -49.05% | 4208.33% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 623.2K | $74.24K | $376.1K |
YoY Change | 175.49% | -80.26% | 263.41% |
NET CHANGE | |||
Cash From Operating Activities | -50.65K | -$395.4K | -$1.316M |
Cash From Investing Activities | -323.8K | -$164.4K | -$322.7K |
Cash From Financing Activities | 623.2K | $74.24K | $376.1K |
Net Change In Cash | 248.8K | -$485.6K | -$1.262M |
YoY Change | -131.23% | -61.53% | 397.05% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$50.65K | -$395.4K | -$1.316M |
Capital Expenditures | $323.8K | $164.4K | $322.7K |
Free Cash Flow | -$374.5K | -$559.9K | -$1.639M |
YoY Change | -63.39% | -65.83% | 378.41% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q3 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000875729 | |
CY2023Q3 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q3 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--06-30 | |
CY2023Q3 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | |
CY2023Q3 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2023Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
usd | |
CY2023Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
usd | |
CY2023Q3 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
usd | |
CY2022Q3 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
usd | |
CY2023Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
usd | |
CY2022Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
usd | |
CY2023Q3 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2022Q3 | us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | |
CY2022Q3 | bnet |
Conversion Of Debt And Liabilities Into Common Units
ConversionOfDebtAndLiabilitiesIntoCommonUnits
|
usd | |
CY2023Q3 | bnet |
Conversion Of Debt And Liabilities Into Notes Payable
ConversionOfDebtAndLiabilitiesIntoNotesPayable
|
usd | |
CY2023Q3 | bnet |
Conversion Of Deferred Compensation To Notes Payable
ConversionOfDeferredCompensationToNotesPayable
|
usd | |
CY2023Q3 | bnet |
Conversion Of Notes Payable Into Shares
ConversionOfNotesPayableIntoShares
|
usd | |
CY2022Q3 | bnet |
Purchase Of Property And Equipment For Accounts Payable
PurchaseOfPropertyAndEquipmentForAccountsPayable
|
usd | |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
shares | |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
||
CY2023Q3 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
shares | |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
||
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
shares | |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
||
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
shares | |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
||
CY2023Q3 | dei |
Document Type
DocumentType
|
10-Q | |
CY2023Q3 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2023Q3 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-09-30 | |
CY2023Q3 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023Q3 | dei |
Entity File Number
EntityFileNumber
|
000-19333 | |
CY2023Q3 | dei |
Entity Registrant Name
EntityRegistrantName
|
Bion Environmental Technologies, Inc. | |
CY2023Q3 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
CO | |
CY2023Q3 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
84-1176672 | |
CY2023Q3 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
9 East Park Court | |
CY2023Q3 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Old Bethpage | |
CY2023Q3 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | |
CY2023Q3 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
11804 | |
CY2023Q3 | dei |
City Area Code
CityAreaCode
|
516 | |
CY2023Q3 | dei |
Local Phone Number
LocalPhoneNumber
|
586-5643 | |
CY2023Q3 | dei |
Security12b Title
Security12bTitle
|
Common Stock | |
CY2023Q3 | dei |
Trading Symbol
TradingSymbol
|
BNET | |
CY2023Q3 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023Q3 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023Q3 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023Q3 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023Q3 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023Q3 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
48796247 | shares |
CY2023Q3 | us-gaap |
Cash
Cash
|
140353 | usd |
CY2023Q2 | us-gaap |
Cash
Cash
|
625964 | usd |
CY2023Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
16280 | usd |
CY2023Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
16785 | usd |
CY2023Q3 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
6000 | usd |
CY2023Q2 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
6000 | usd |
CY2023Q3 | us-gaap |
Assets Current
AssetsCurrent
|
162633 | usd |
CY2023Q2 | us-gaap |
Assets Current
AssetsCurrent
|
648749 | usd |
CY2023Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
80188 | usd |
CY2023Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
93875 | usd |
CY2023Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
7620661 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
6851009 | usd |
CY2023Q3 | us-gaap |
Assets
Assets
|
7863482 | usd |
CY2023Q2 | us-gaap |
Assets
Assets
|
7593633 | usd |
CY2023Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1269482 | usd |
CY2023Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
677136 | usd |
CY2023Q3 | us-gaap |
Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
|
1073708 | usd |
CY2023Q2 | us-gaap |
Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
|
864781 | usd |
CY2023Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
75000 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
75000 | usd |
CY2023Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2418190 | usd |
CY2023Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1616917 | usd |
CY2023Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
12784 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
29068 | usd |
CY2023Q3 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
1683966 | usd |
CY2023Q2 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
1715970 | usd |
CY2023Q3 | us-gaap |
Liabilities
Liabilities
|
4114940 | usd |
CY2023Q2 | us-gaap |
Liabilities
Liabilities
|
3361955 | usd |
CY2023Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0 | |
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0 | |
CY2023Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
250000000 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
49485556 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
48880237 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
48781247 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
48175928 | shares |
CY2023Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
132197829 | usd |
CY2023Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
131935418 | usd |
CY2023Q3 | us-gaap |
Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
|
504650 | usd |
CY2023Q2 | us-gaap |
Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
|
504650 | usd |
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-127982210 | usd |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-127236663 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3710969 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
4194105 | usd |
CY2023Q3 | us-gaap |
Minority Interest
MinorityInterest
|
37573 | usd |
CY2023Q2 | us-gaap |
Minority Interest
MinorityInterest
|
37573 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
3748542 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
4231678 | usd |
CY2023Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
7863482 | usd |
CY2023Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
7593633 | usd |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
666255 | usd |
CY2022Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
866494 | usd |
CY2023Q3 | us-gaap |
Depreciation
Depreciation
|
461 | usd |
CY2022Q3 | us-gaap |
Depreciation
Depreciation
|
330 | usd |
CY2023Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
8299 | usd |
CY2022Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
28443 | usd |
CY2023Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
675015 | usd |
CY2022Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
895267 | usd |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-675015 | usd |
CY2022Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-895267 | usd |
CY2022Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
154933 | usd |
CY2023Q3 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
27987 | usd |
CY2023Q3 | us-gaap |
Interest Income Operating
InterestIncomeOperating
|
395 | usd |
CY2022Q3 | us-gaap |
Interest Income Operating
InterestIncomeOperating
|
1935 | usd |
CY2023Q3 | bnet |
Interests Expense
InterestsExpense
|
70927 | usd |
CY2022Q3 | bnet |
Interests Expense
InterestsExpense
|
26095 | usd |
CY2023Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-70532 | usd |
CY2022Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-24160 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-745547 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-919427 | usd |
CY2023Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-745547 | usd |
CY2022Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-919427 | usd |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
CY2022Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | |
CY2022Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
48617675 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
48617675 | shares |
CY2022Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
43451846 | shares |
CY2022Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
43451846 | shares |
CY2022Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-894579 | usd |
CY2022Q3 | bnet |
Sale Of Units Value
SaleOfUnitsValue
|
320000 | usd |
CY2022Q3 | bnet |
Warrants Exercised For Common Shares
WarrantsExercisedForCommonShares
|
56125 | usd |
CY2022Q3 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
80000 | usd |
CY2022Q3 | bnet |
Issuance Of Warrants For Services
IssuanceOfWarrantsForServices
|
15000 | usd |
CY2022Q3 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
50000 | usd |
CY2022Q3 | bnet |
Adjustment To Additional Paid In Capital Modification Of Warrants
AdjustmentToAdditionalPaidInCapitalModificationOfWarrants
|
159433 | usd |
CY2022Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-919427 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1133448 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
4231678 | usd |
CY2023Q3 | bnet |
Sale Of Units Value
SaleOfUnitsValue
|
45742 | usd |
CY2023Q3 | bnet |
Warrants Exercised For Common Shares
WarrantsExercisedForCommonShares
|
28500 | usd |
CY2023Q3 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
27987 | usd |
CY2023Q3 | bnet |
Vesting Of Options For Employees And Services
VestingOfOptionsForEmployeesAndServices
|
55108 | usd |
CY2023Q3 | bnet |
Vesting Of Warrants For Employees And Services
VestingOfWarrantsForEmployeesAndServices
|
3281 | usd |
CY2023Q3 | bnet |
Debt Modification
DebtModification
|
-8430 | usd |
CY2023Q3 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
49048 | usd |
CY2023Q3 | bnet |
Adjustment To Additional Paid In Capital Modification Of Warrants
AdjustmentToAdditionalPaidInCapitalModificationOfWarrants
|
61175 | usd |
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-745547 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
3748542 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-745547 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-919427 | usd |
CY2023Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
461 | usd |
CY2022Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
330 | usd |
CY2023Q3 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
70927 | usd |
CY2022Q3 | us-gaap |
Other Noncash Expense
OtherNoncashExpense
|
26096 | usd |
CY2023Q3 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
58389 | usd |
CY2022Q3 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
95000 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-505 | usd |
CY2022Q3 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-23297 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-8071 | usd |
CY2022Q3 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-787276 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-2596 | usd |
CY2022Q3 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
16155 | usd |
CY2023Q3 | us-gaap |
Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
|
202500 | usd |
CY2022Q3 | us-gaap |
Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
|
75000 | usd |
CY2023Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-395445 | usd |
CY2022Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1315892 | usd |
CY2023Q3 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
164408 | usd |
CY2022Q3 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
322694 | usd |
CY2023Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-164408 | usd |
CY2022Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-322694 | usd |
CY2023Q3 | bnet |
Proceeds From Sale Of Units
ProceedsFromSaleOfUnits
|
45742 | usd |
CY2022Q3 | bnet |
Proceeds From Sale Of Units
ProceedsFromSaleOfUnits
|
320000 | usd |
CY2023Q3 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
28500 | usd |
CY2022Q3 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
56125 | usd |
CY2023Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
74242 | usd |
CY2022Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
376125 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-485611 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-1262461 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
625964 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3160442 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
140353 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1897981 | usd |
CY2023Q3 | bnet |
Conversion Of Debt And Liabilities Into Common Units
ConversionOfDebtAndLiabilitiesIntoCommonUnits
|
49048 | usd |
CY2022Q3 | bnet |
Conversion Of Debt And Liabilities Into Notes Payable
ConversionOfDebtAndLiabilitiesIntoNotesPayable
|
23943 | usd |
CY2022Q3 | bnet |
Conversion Of Deferred Compensation To Notes Payable
ConversionOfDeferredCompensationToNotesPayable
|
20000 | usd |
CY2022Q3 | bnet |
Conversion Of Notes Payable Into Shares
ConversionOfNotesPayableIntoShares
|
50000 | usd |
CY2023Q3 | bnet |
Purchase Of Property And Equipment For Accounts Payable
PurchaseOfPropertyAndEquipmentForAccountsPayable
|
600416 | usd |
CY2023Q3 | bnet |
Cattle Per Head
CattlePerHead
|
300 | decimal |
CY2023Q3 | bnet |
Techwastage
Techwastage
|
1500 | decimal |
CY2022Q1 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
2665500 | usd |
CY2022Q1 | us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.25 | pure |
CY2022Q1 | bnet |
Debt Instrument Periodic Payments
DebtInstrumentPeriodicPayments
|
666375 | usd |
CY2022Q1 | us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.25 | pure |
CY2022Q2 | us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.25 | pure |
CY2023Q1 | us-gaap |
Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
|
533100 | usd |
CY2023Q2 | us-gaap |
Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
|
83275 | usd |
CY2023Q2 | bnet |
Aggregate Payment
AggregatePayment
|
2615500 | usd |
CY2023Q3 | bnet |
Purchase Order
PurchaseOrder
|
50000 | usd |
CY2023Q3 | bnet |
Additional Interest Costs Incurred Capitalized
AdditionalInterestCostsIncurredCapitalized
|
5018760 | usd |
CY2023Q3 | bnet |
Interest Costs Capitalized Paid
InterestCostsCapitalizedPaid
|
7044902 | usd |
CY2023Q3 | us-gaap |
Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
|
220053 | usd |
CY2023Q3 | us-gaap |
Interest Costs Incurred
InterestCostsIncurred
|
6784813 | usd |
CY2023Q3 | bnet |
Percentage Of Sustainable
PercentageOfSustainable
|
0.295 | pure |
CY2023Q3 | bnet |
Description Of Kreider2 Poultry Project
DescriptionOfKreider2PoultryProject
|
Bion has done extensive pre-development work related to a waste treatment/renewable energy production facility to treat the waste from KF’s approximately 6+ million chickens (planned to expand to approximately 9-10 million) (and potentially other poultry operations and/or other waste streams) (‘Kreider Renewable Energy Facility’ or ‘Kreider 2 Project’). On May 5, 2016, the Company executed a stand-alone joint venture agreement (“JVA”) with Kreider Farms covering all matters related to development and operation of Kreider 2 system to treat the waste streams from Kreider’s poultry facilities in Bion PA2 LLC (“PA2”). Now that development of the Company’s Gen3Tech is being deployed, the Company has commenced discussions with KF regarding updating and amending the JV agreement and anticipates executing an amended joint venture agreement during 2023. During May 2011 the PADEP certified a smaller version of the Kreider 2 Project (utilizing our 2nd generation technology) under the old EPA’s Chesapeake Bay model. The Company anticipates that if and when new designs are finalized utilizing our Gen3Tech, a larger Kreider 2 Project will be re-certified for a far larger number of credits (management’s current estimates are between 2-4 million (or more) nutrient reduction credits for treatment of the waste stream from Kreider’s poultry pursuant to the amended EPA Chesapeake Bay model and agreements between the EPA and PA). | |
CY2022 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
8291000 | usd |
CY2023 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
3189000 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
10235000 | usd |
CY2022 | bnet |
Gain On Sale Of Domain Amount
GainOnSaleOfDomainAmount
|
902000 | usd |
CY2023 | bnet |
Reduction Of Debt
ReductionOfDebt
|
3516000 | usd |
CY2023Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
746000 | usd |
CY2022Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
919000 | usd |
CY2023Q3 | bnet |
Working Capital
WorkingCapital
|
2181000 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity Other
StockholdersEquityOther
|
3717000 | usd |
CY2023 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
4038000 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
1737000 | usd |
CY2023Q3 | bnet |
Payments To Warrant Exercises Commissions
PaymentsToWarrantExercisesCommissions
|
86000 | usd |
CY2022Q3 | bnet |
Payments To Warrant Exercises Commissions
PaymentsToWarrantExercisesCommissions
|
19000 | usd |
CY2023Q3 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
74000 | usd |
CY2022Q3 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
376000 | usd |
CY2018 | bnet |
Deferred Compensation Liability Amount Cancelled
DeferredCompensationLiabilityAmountCancelled
|
2404000 | usd |
CY2023Q3 | bnet |
Reduction Of Debt
ReductionOfDebt
|
3516000 | usd |
CY2023Q3 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
CY2023Q2 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
CY2023Q3 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zQRr4zt5awB6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_869_zg6an19HNE1">Concentrations of credit risk:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times may exceed federally insured limits. The Company has not experienced any losses on such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> | |
CY2023Q3 | bnet |
Shares Issued Beginning Of Period
SharesIssuedBeginningOfPeriod
|
48880237 | shares |
CY2022Q3 | bnet |
Shares Issued Beginning Of Period
SharesIssuedBeginningOfPeriod
|
43758820 | shares |
CY2023Q3 | bnet |
Shares Held By Subsidiaries
SharesHeldBySubsidiaries
|
-704309 | shares |
CY2022Q3 | bnet |
Shares Held By Subsidiaries
SharesHeldBySubsidiaries
|
-704309 | shares |
CY2023Q3 | bnet |
Shares Outstanding Beginning Of Period
SharesOutstandingBeginningOfPeriod
|
48175928 | shares |
CY2022Q3 | bnet |
Shares Outstanding Beginning Of Period
SharesOutstandingBeginningOfPeriod
|
43054511 | shares |
CY2023Q3 | bnet |
Weighted Average Shares Issued During Period
WeightedAverageSharesIssuedDuringPeriod
|
441747 | shares |
CY2022Q3 | bnet |
Weighted Average Shares Issued During Period
WeightedAverageSharesIssuedDuringPeriod
|
397335 | shares |
CY2023Q3 | bnet |
Weighted Average Number Of Diluted Share Outstanding
WeightedAverageNumberOfDilutedShareOutstanding
|
48617675 | shares |
CY2022Q3 | bnet |
Weighted Average Number Of Diluted Share Outstanding
WeightedAverageNumberOfDilutedShareOutstanding
|
43451846 | shares |
CY2023Q3 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_842_eus-gaap--UseOfEstimates_zmNu4yQoXiEh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86B_z3TT59FRHrK6">Use of estimates:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing the Company’s condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> | |
CY2023Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
7633029 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
6862916 | usd |
CY2023Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
12368 | usd |
CY2023Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
11907 | usd |
CY2023Q3 | us-gaap |
Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
|
7620661 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
|
6851009 | usd |
CY2023Q3 | us-gaap |
Interest Costs Capitalized
InterestCostsCapitalized
|
217269 | usd |
CY2022Q3 | us-gaap |
Interest Costs Capitalized
InterestCostsCapitalized
|
62688 | usd |
CY2023Q3 | bnet |
Non Cash Compensation
NonCashCompensation
|
135648 | usd |
CY2022Q3 | bnet |
Non Cash Compensation
NonCashCompensation
|
135648 | usd |
CY2023Q3 | us-gaap |
Depreciation
Depreciation
|
461 | usd |
CY2022Q3 | us-gaap |
Depreciation
Depreciation
|
330 | usd |
CY2023Q3 | us-gaap |
Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
|
1073708 | usd |
CY2022Q3 | us-gaap |
Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
|
654349 | usd |
CY2023Q3 | bnet |
Interest Rate On Deferred Compensation
InterestRateOnDeferredCompensation
|
0.04 | pure |
CY2023Q3 | bnet |
Deferred Compensation Consecutive Trading Days
DeferredCompensationConsecutiveTradingDays
|
P10D | |
CY2023Q3 | us-gaap |
Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
|
192500 | usd |
CY2022Q3 | us-gaap |
Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
|
50000 | usd |
CY2021Q3 | us-gaap |
Assets
Assets
|
297 | usd |
CY2021Q3 | us-gaap |
Liabilities
Liabilities
|
10154334 | usd |
CY2021Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
9939148 | usd |
CY2021Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
214235 | usd |
CY2021Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
950 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
10234501 | usd |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
10009802 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
212263 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
12436 | usd |
CY2023Q3 | us-gaap |
Gain Or Loss On Sale Of Stock In Subsidiary
GainOrLossOnSaleOfStockInSubsidiary
|
10234501 | usd |
CY2021Q2 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
9868495 | usd |
CY2023Q1 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
3470000 | usd |
CY2023Q3 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.50 | |
CY2023Q3 | us-gaap |
Costs Incurred Development Costs
CostsIncurredDevelopmentCosts
|
71646 | usd |
CY2022Q3 | us-gaap |
Costs Incurred Development Costs
CostsIncurredDevelopmentCosts
|
30688 | usd |
CY2023Q1 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
3470000 | usd |
CY2023Q1 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
3470000 | usd |
CY2023 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
3522000 | usd |
CY2023 | bnet |
Reduction Of Additional Paid In Capital
ReductionOfAdditionalPaidInCapital
|
14051 | usd |
CY2023Q3 | bnet |
Debt Modifications
DebtModifications
|
8430 | usd |
CY2023Q3 | bnet |
Shares Held By Subsidiaries
SharesHeldBySubsidiaries
|
-704309 | shares |
CY2023Q3 | bnet |
Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
|
38000 | shares |
CY2023Q3 | bnet |
Common Stock Shares Issued Upon Exercise Of Warrants
CommonStockSharesIssuedUponExerciseOfWarrants
|
38000 | shares |
CY2023Q3 | bnet |
Total Proceeds
TotalProceeds
|
28500 | usd |
CY2023Q3 | bnet |
Exercise Bonus
ExerciseBonus
|
0.75 | pure |
CY2023Q3 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
23000000 | shares |
CY2023Q3 | bnet |
Sale Of Warrants
SaleOfWarrants
|
1003590 | shares |
CY2023Q3 | us-gaap |
Warrant Exercise Price Increase
WarrantExercisePriceIncrease
|
1.25 | |
CY2023Q3 | us-gaap |
Shares Issued
SharesIssued
|
501795 | shares |
CY2023Q3 | us-gaap |
Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
|
2023-10-01 | |
CY2023Q3 | bnet |
Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
|
38000 | shares |
CY2023Q3 | bnet |
Common Stock Shares Issued Upon Exercise Of Warrants
CommonStockSharesIssuedUponExerciseOfWarrants
|
38000 | shares |
CY2023Q3 | bnet |
Warrants Exercised For Common Stock
WarrantsExercisedForCommonStock
|
28500 | usd |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
12006600 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.85 | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P1Y9M29D | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
5085659 | usd |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
12006600 | shares |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.85 | |
CY2023Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P1Y6M25D | |
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
3387603 | usd |
CY2023Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
0 | usd |
CY2022Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
0 | usd |
CY2022Q2 | bnet |
Compensation Increased
CompensationIncreased
|
25000 | usd |
CY2021Q2 | bnet |
Exercise Price
ExercisePrice
|
0.75 | pure |
CY2021 | bnet |
Warrants Held By Trust Owned
WarrantsHeldByTrustOwned
|
3000000 | usd |
CY2023Q3 | bnet |
Warrants And Right Outstanding
WarrantsAndRightOutstanding
|
19659372 | shares |
CY2022Q1 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
2665500 | usd |
CY2022Q1 | us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.25 | pure |
CY2022Q1 | us-gaap |
Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
|
666375 | usd |
CY2022Q2 | us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.25 | pure |
CY2023Q1 | us-gaap |
Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
|
533100 | usd |
CY2023Q2 | us-gaap |
Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
|
83275 | usd |
CY2023Q2 | bnet |
Aggregate Payment
AggregatePayment
|
2615500 | usd |
CY2023Q3 | bnet |
Purchase Order
PurchaseOrder
|
50000 | usd |
CY2023Q3 | us-gaap |
Interest Costs Incurred Capitalized
InterestCostsIncurredCapitalized
|
5018730 | usd |
CY2023Q3 | bnet |
Interest Costs Capitalized Paid
InterestCostsCapitalizedPaid
|
7044902 | usd |
CY2023Q3 | us-gaap |
Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
|
220053 | usd |
CY2023Q3 | us-gaap |
Interest Costs Incurred
InterestCostsIncurred
|
6784813 | usd |
CY2022Q1 | bnet |
Sale Of Domain Description
SaleOfDomainDescription
|
the Company entered into an agreement to sell domain name <biontech.com> and other related assets to BioNTech SE (“BNTX”) for the sum of $950,000 (before expenses related to the transaction) which sale was closed/completed on April 2, 2022 with a one-time gain of $902,490. | |
CY2021Q4 | us-gaap |
Long Term Construction Loan Current
LongTermConstructionLoanCurrent
|
10010000 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
|
2255802 | usd |
CY2021Q3 | us-gaap |
Assets
Assets
|
297 | usd |
CY2021Q3 | us-gaap |
Liabilities
Liabilities
|
10154334 | usd |
CY2021Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
9939148 | usd |
CY2021Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
214235 | usd |
CY2021Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
950 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
10234501 | usd |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
10009802 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
212263 | usd |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
12436 | usd |
CY2023Q3 | us-gaap |
Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
|
10234501 | usd |
CY2021Q2 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
9868495 | usd |
CY2023Q2 | bnet |
Bank Account Hacked Amount
BankAccountHackedAmount
|
75000 | usd |
CY2023Q3 | bnet |
Operating Leases Future Minimum Payment Receivable In Two Years
OperatingLeasesFutureMinimumPaymentReceivableInTwoYears
|
18750 | usd |
CY2023Q3 | bnet |
Operating Leases Future Minimum Payment Receivable In Three Years
OperatingLeasesFutureMinimumPaymentReceivableInThreeYears
|
75000 | usd |
CY2023Q3 | bnet |
Undiscounted Cash Flow
UndiscountedCashFlow
|
93750 | usd |
CY2023Q3 | bnet |
Less Imputed Interest
LessImputedInterest
|
-5966 | usd |
CY2023Q3 | bnet |
Capital Leases Contingent Rental Payment Due
CapitalLeasesContingentRentalPaymentDue
|
87784 | usd |
CY2023Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y3M29D | |
CY2023Q3 | us-gaap |
Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
|
0.10 | pure |
CY2023Q4 | bnet |
Deferred Compensation Amount
DeferredCompensationAmount
|
80767 | usd |
CY2023Q4 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
117553 | usd |
CY2023Q4 | us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
235106 | shares |
CY2023Q3 | bnet |
Sale Of Warrants
SaleOfWarrants
|
1003590 | shares |
CY2023Q3 | us-gaap |
Warrant Exercise Price Increase
WarrantExercisePriceIncrease
|
1.25 | |
CY2023Q3 | us-gaap |
Shares Issued
SharesIssued
|
501795 | shares |
CY2023Q3 | us-gaap |
Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
|
2023-10-01 |